[home]
[thesaurus]
Click Here to return To Results
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
JAMA 314:2227, , 2015
See this aricle in Pubmed
Article Abstract
No abstract available for this article
Related Tags
(click to filter results - removes previous filter)
anticoagulant,complications of
anticoagulant,reversal of
dabigatran
efficacy
factor Xa inhibitor
idarucizumab
safety
Click Here to return To Results